{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8647566", "DateCompleted": {"Year": "1996", "Month": "07", "Day": "19"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["ger"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0015-8178", "JournalIssue": {"Volume": "114", "Issue": "1-2", "PubDate": {"Year": "1996", "Month": "Jan", "Day": "20"}}, "Title": "Fortschritte der Medizin", "ISOAbbreviation": "Fortschr Med"}, "ArticleTitle": "[Therapeutic effectiveness of Crataegus].", "Pagination": {"StartPage": "27", "EndPage": "29", "MedlinePgn": "27-9"}, "Abstract": {"AbstractText": ["Hawthorn (crataegus) has been used since antiquity for medicinal purposes. More recent research suggests it to be useful in congestive heart failure. Rigorous clinical trials show benefit concerning objective signs and subjective symptoms of congestive heart failure stage NYHA-II. No adverse drug reactions have been reported. It is therefore concluded that crataegus is an effective and safe therapeutic alternative for this indication."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hom\u00f6opathie-Naturheilverfahren, M\u00fcnchen."}], "LastName": "Weihmayr", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ernst", "ForeName": "E", "Initials": "E"}], "PublicationTypeList": ["Clinical Trial", "English Abstract", "Journal Article", "Multicenter Study", "Randomized Controlled Trial", "Review"], "VernacularTitle": "Die therapeutische Wirksamkeit von Crataegus."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Fortschr Med", "NlmUniqueID": "2984763R", "ISSNLinking": "0015-8178"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiotensin-Converting Enzyme Inhibitors"}, {"RegistryNumber": "9G64RSX1XD", "NameOfSubstance": "Captopril"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Angiotensin-Converting Enzyme Inhibitors"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Captopril"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["rehabilitation"], "DescriptorName": "Heart Failure"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Medicine, Traditional"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}], "NumberOfReferences": "30"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1996", "Month": "1", "Day": "20"}, {"Year": "1996", "Month": "1", "Day": "20", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "1", "Day": "20", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8647566"]}}]}